Pertussis Market to Witness Upsurge in Growth During the Forecast Period (2023-2032), Examine DelveInsight | ILiAD Biotechnologies, Mitsubishi Tanabe Pharma Corporation, Serum Institute, Bilthoven, VPM, Meridian Bioscience Inc, bioMerieux SA

DelveInsight's "Pertussis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Pertussis, historical and forecasted epidemiology as well as the Pertussis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Pertussis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Pertussis Market Forecast
https://www.delveinsight.com/sample-request/pertussis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Pertussis Market Report:
• The Pertussis market size was valued approximately USD 3,538 Million in 2021 and is anticipated to grow with a significant CAGR during the study period (2019-2032)
• Pertussis, usually referred to as whooping cough and literally meaning "a violent cough," is an acute respiratory infection brought on by the Bordetella pertussis bacteria. Pertussis progresses through three stages: catarrhal, paroxysmal, and convalescent
• The CDC (2020) regularly advises five doses of the DTaP vaccine at 2, 4, and 6 months, at 15-18 months, and at 4-6 years, and suggests Tdap for kids aged 7-10 who have not had their full dosage of the pertussis vaccine
• The National Health System Real-World Data was examined in the Marchal et al. (2021) study to ascertain the vaccine coverage rates (VCRs) for the booster doses of Diphtheria, Tetanus, Poliomyelitis, and Pertussis in France
• In 2021, there were 34,649,297 people who had received their entire 7MM dose of the pertussis vaccination
• Germany had the most vaccines out of the EU5 states, followed by France (2,619,428) and Italy (2,277,856). The UK had the fewest vaccines (2,643,017) in 2021, in comparison
• Key Pertussis Companies: ILiAD Biotechnologies, Mitsubishi Tanabe Pharma Corporation, Serum Institute, Bilthoven, VPM, Meridian Bioscience Inc, bioMerieux SA, Luminex Corp, Quidel Corp, Tecan Group Ltd, Euroimmun AG, Hologic Inc, STAT-Dx, and others
• Key Pertussis Therapies: BPZE1, BK1310, MT-2355, SIIPL Tdap, and others
• The Pertussis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Pertussis pipeline products will significantly revolutionize the Pertussis market dynamics.

Get a Free sample for the Pertussis Market Report
https://www.delveinsight.com/report-store/pertussis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Pertussis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Pertussis Epidemiology Segmentation:
The Pertussis market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Pertussis
• Prevalent Cases of Pertussis by severity
• Gender-specific Prevalence of Pertussis
• Diagnosed Cases of Episodic and Chronic Pertussis

Download the report to understand which factors are driving Pertussis epidemiology trends @ Pertussis Epidemiology Forecast
https://www.delveinsight.com/sample-request/pertussis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Pertussis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Pertussis market or expected to get launched during the study period. The analysis covers Pertussis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Pertussis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Pertussis Therapies and Key Companies
• BPZE1: ILiAD Biotechnologies
• BK1310/MT-2355: Mitsubishi Tanabe Pharma Corporation
• SIIPL Tdap: Serum Institute/Bilthoven/VPM

Discover more about therapies set to grab major Pertussis market share @ Pertussis Treatment Market
https://www.delveinsight.com/sample-request/pertussis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Pertussis Market Drivers
• Increase in the recommendation of vaccination programs in pregnant women
• Increasing Awareness Programs
• Increasing population of pertussis

Pertussis Market Barriers
• Acellular vaccines less effective in the current market
• Lack of patient awareness
• Barriers to developing a new whole-cell version of pertussis vaccine
• Different vaccination policies amongst various countries

Scope of the Pertussis Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Pertussis Companies: ILiAD Biotechnologies, Mitsubishi Tanabe Pharma Corporation, Serum Institute, Bilthoven, VPM, Meridian Bioscience Inc, bioMerieux SA, Luminex Corp, Quidel Corp, Tecan Group Ltd, Euroimmun AG, Hologic Inc, STAT-Dx, and others
• Key Pertussis Therapies: BPZE1, BK1310, MT-2355, SIIPL Tdap, and others
• Pertussis Therapeutic Assessment: Pertussis current marketed and Pertussis emerging therapies
• Pertussis Market Dynamics: Pertussis market drivers and Pertussis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Pertussis Unmet Needs, KOL's views, Analyst's views, Pertussis Market Access and Reimbursement

To know more about Pertussis companies working in the treatment market, visit @ Pertussis Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/pertussis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. Pertussis Market Report Introduction
2. Executive Summary for Pertussis
3. SWOT analysis of Pertussis
4. Pertussis Patient Share (%) Overview at a Glance
5. Pertussis Market Overview at a Glance
6. Pertussis Disease Background and Overview
7. Pertussis Epidemiology and Patient Population
8. Country-Specific Patient Population of Pertussis
9. Pertussis Current Treatment and Medical Practices
10. Pertussis Unmet Needs
11. Pertussis Emerging Therapies
12. Pertussis Market Outlook
13. Country-Wise Pertussis Market Analysis (2019-2032)
14. Pertussis Market Access and Reimbursement of Therapies
15. Pertussis Market Drivers
16. Pertussis Market Barriers
17. Pertussis Appendix
18. Pertussis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Related Reports:
Pertussis Pipeline https://www.delveinsight.com/report-store/pertussis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Pertussis Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Pertussis market. A detailed picture of the Pertussis pipeline landscape is provided, which includes the disease overview and Pertussis treatment guidelines.
Pertussis Epidemiology https://www.delveinsight.com/report-store/pertussis-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Pertussis Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Pertussis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight
Monkeypox Market https://www.delveinsight.com/report-store/monkeypox-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Monkeypox Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Monkeypox, historical and forecasted epidemiology as well as the Monkeypox market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Pars Planitis Market
https://www.delveinsight.com/report-store/pars-plantis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Pars Plantis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Pars Plantis, historical and forecasted epidemiology as well as the Pars Plantis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Patient Monitoring Devices Market
https://www.delveinsight.com/report-store/patient-monitoring-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Patient Monitoring Devices Market By Type Of Devices (Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Blood Glucose Monitoring Systems, And Others), By Application (Cardiology, Neurology, Respiratory, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings, And Others), by geography, is anticipated to grow at a significant CAGR till 2028 owing to the growing prevalence of various chronic disorders and integration of advanced technology in the products

Typhoid Market https://www.delveinsight.com/report-store/typhoid-fever-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Typhoid Fever Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Typhoid Fever, historical and forecasted epidemiology as well as the Typhoid Fever market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Zika Virus Market https://www.delveinsight.com/report-store/zika-virus-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Zika Virus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Zika Virus, historical and forecasted epidemiology as well as the Zika Virus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Opioid Use Disorder Market https://www.delveinsight.com/report-store/opioid-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Opioid Use Disorder (OUD) - Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Opioid Use Disorder (OUD), historical and forecasted epidemiology as well as the Opioid Use Disorder (OUD) market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Recent Blog's By DelveInsight:

• Insights Into The Cutaneous T-cell Lymphoma Treatment Market
https://www.delveinsight.com/blog/cutaneous-t-cell-lymphoma-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Roche's HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape
https://www.delveinsight.com/blog/hemlibra-for-hemophilia-a-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Emerging Role of Digital Health in the Field of Oncology
https://www.delveinsight.com/blog/digital-health-to-improve-cancer-management?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How Will Emerging Therapies Drift the Amyotrophic Lateral Sclerosis (ALS) Treatment Landscape
https://www.delveinsight.com/blog/evolving-als-treatment-landscape?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How are Technological Trends and Innovations Reshaping the Dementia Care
https://www.delveinsight.com/blog/technological-innovations-in-dementia-care?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market
https://www.delveinsight.com/blog/clinical-diagnostics-market-outlook?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Non-opioid Analgesics Chronic Pain Treatment: Savior of Underserved Patients
https://www.delveinsight.com/blog/non-opioid-analgesics-for-chronic-pain-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Limited Availability and Lack of Access are Unlikely to Hinder the Billion-Dollar Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market
https://www.delveinsight.com/blog/alpha-1-antitrypsin-deficiency-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Evaluating the Key Trends and Technologies Shaping the Future of Dentistry https://www.delveinsight.com/blog/emerging-trends-in-dental-care-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr

Media Contact

Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.